Soluble E-cadherin-CXCL1-CXCR2 axis as a therapeutic vulnerability in inflammatory breast cancer brain metastasis.
Saved in:
| Title: | Soluble E-cadherin-CXCL1-CXCR2 axis as a therapeutic vulnerability in inflammatory breast cancer brain metastasis. |
|---|---|
| Authors: | Hu X; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston., Xiong Y; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston., Villodre ES; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston., Zhang H; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston., Longa IR; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston., Song J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston., Fowlkes N; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston., Krishnamurthy S; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston., Rylander M; Department of Biomedical Engineering, The University of Texas at Austin, Austin., Bartholomeusz C; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston., Tripathy D; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston., Woodward WA; Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston., Chen J; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston., Debeb BG; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston. |
| Source: | Neuro-oncology [Neuro Oncol] 2026 May 01; Vol. 28 (5), pp. 1220-1236. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41578012 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Soluble E-cadherin-CXCL1-CXCR2 axis as a therapeutic vulnerability in inflammatory breast cancer brain metastasis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hu+X%22">Hu X</searchLink>; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Xiong+Y%22">Xiong Y</searchLink>; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Villodre+ES%22">Villodre ES</searchLink>; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Zhang+H%22">Zhang H</searchLink>; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Longa+IR%22">Longa IR</searchLink>; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Song+J%22">Song J</searchLink>; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Fowlkes+N%22">Fowlkes N</searchLink>; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Krishnamurthy+S%22">Krishnamurthy S</searchLink>; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Rylander+M%22">Rylander M</searchLink>; Department of Biomedical Engineering, The University of Texas at Austin, Austin.<br /><searchLink fieldCode="AU" term="%22Bartholomeusz+C%22">Bartholomeusz C</searchLink>; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Tripathy+D%22">Tripathy D</searchLink>; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Woodward+WA%22">Woodward WA</searchLink>; Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Chen+J%22">Chen J</searchLink>; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Debeb+BG%22">Debeb BG</searchLink>; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.; MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100887420%22">Neuro-oncology</searchLink> [Neuro Oncol] 2026 May 01; Vol. 28 (5), pp. 1220-1236. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100887420 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1523-5866 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215228517%22">15228517 </searchLink><i>NLM ISO Abbreviation: </i>Neuro Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41578012 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/neuonc/noag012 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1220 Titles: – TitleFull: Soluble E-cadherin-CXCL1-CXCR2 axis as a therapeutic vulnerability in inflammatory breast cancer brain metastasis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hu X – PersonEntity: Name: NameFull: Xiong Y – PersonEntity: Name: NameFull: Villodre ES – PersonEntity: Name: NameFull: Zhang H – PersonEntity: Name: NameFull: Longa IR – PersonEntity: Name: NameFull: Song J – PersonEntity: Name: NameFull: Fowlkes N – PersonEntity: Name: NameFull: Krishnamurthy S – PersonEntity: Name: NameFull: Rylander M – PersonEntity: Name: NameFull: Bartholomeusz C – PersonEntity: Name: NameFull: Tripathy D – PersonEntity: Name: NameFull: Woodward WA – PersonEntity: Name: NameFull: Chen J – PersonEntity: Name: NameFull: Debeb BG IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1523-5866 Numbering: – Type: volume Value: 28 – Type: issue Value: 5 Titles: – TitleFull: Neuro-oncology Type: main |
| ResultId | 1 |